Cargando…

Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States

Background: Acute respiratory infections (ARIs) are commonly treated with antibiotics in outpatient settings, but many infections are caused by viruses and antibiotic treatment is therefore inappropriate. FebriDx®, a rapid point-of-care test that can differentiate viral from bacterial infections, ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dick, Katherine, Schneider, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2021
Materias:	Respiratory Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483888/ https://www.ncbi.nlm.nih.gov/pubmed/34703832 http://dx.doi.org/10.36469/001c.27753

Ejemplares similares

FebriDx(®): A Rapid Diagnostic Test for Differentiating Bacterial and Viral Aetiologies in Acute Respiratory Infections
por: Shirley, Matt
Publicado: (2019)

Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections
por: Self, Wesley H., et al.
Publicado: (2017)

Utility of the FebriDx point-of-care assay in supporting a triage algorithm for medical admissions with possible COVID-19: an observational cohort study
por: Houston, Hamish, et al.
Publicado: (2021)

Utility of the FebriDx point‐of‐care test for rapid triage and identification of possible coronavirus disease 2019 (COVID‐19)
por: Karim, Nawazish, et al.
Publicado: (2020)

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19
por: Clark, Tristan W., et al.
Publicado: (2020)

FebriDx for rapid screening of patients with suspected COVID-19 upon hospital admission: systematic literature review and meta-analysis
por: Lippi, G., et al.
Publicado: (2022)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department – ADDENDUM
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

1034. FebriDx use in Immunocompromised Patients in a Real-World Hospital Setting during the second (COVID-19) wave in Italy
por: Lagi, Filippo, et al.
Publicado: (2021)

2023. A Prospective, Multi-Center U.S. Clinical Trial to Determine Accuracy of FebriDx Point-of-Care Testing for Acute Upper Respiratory Infections with and Without a Confirmed Fever
por: Sambursky, Robert, et al.
Publicado: (2018)

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy
por: Lagi, Filippo, et al.
Publicado: (2021)

Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study
por: Buntine, Paul, et al.
Publicado: (2022)

Economic Impact of Changes in Neonatal Intensive Care Unit Ventilation Strategies with the Advent of New Noninvasive Ventilation Techniques: A Review and Proposed Assessment Framework for High Flow Therapy as a Routine Respiratory Support Paradigm
por: Pietzsch, Jan B., et al.
Publicado: (2015)

The Burden of Hypoxic Respiratory Failure in Preterm and Term/Near-term Infants in the United States 2011-2015
por: Pandya, Shivani, et al.
Publicado: (2019)

Cost Impact Model of a Novel Multi-mRNA Host Response Assay for Diagnosis and Risk Assessment of Acute Respiratory Tract Infections and Sepsis in the Emergency Department
por: Schneider, John E., et al.
Publicado: (2020)

Early life exposures and risk of adult respiratory disease during 50 years of follow-up
por: Johansson, Carl J., et al.
Publicado: (2020)

Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England
por: Attar-Zadeh, Darsuh, et al.
Publicado: (2021)

Montelukast Use and Patterns of Ambulatory Care among Asian versus Non-Asian Adult Patients with Asthma and/or Allergic Rhinitis in the United States
por: Vasey, Joseph, et al.
Publicado: (2015)

654. Evaluation of the Febridx Host Response Point-of-Care Test to Differentiate Viral From Bacterial Etiology in Adults Hospitalized with Acute Respiratory Illness During Influenza Season
por: Beard, Kate, et al.
Publicado: (2019)

Febris Nigra—“Black Death”
Publicado: (1866)

Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
por: Hunter, Jennifer, et al.
Publicado: (2021)

On the Cure of the Febris Intermittens, by the Ammonia Preparata
por: Rainbird, Philip
Publicado: (1806)

On the Recent Outbreak of “Febris Nigra” in Dublin
por: Lyons, Robert D.
Publicado: (1868)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

Mother’s education and offspring asthma risk in 10 European cohort studies
por: Lewis, Kate Marie, et al.
Publicado: (2017)

Patient-Centric Structural Determinants of Adherence Rates Among Asthma Populations: Exploring the Potential of Patient Activation and Encouragement Tool TRUSTR to Improve Adherence
por: Zia, Asim, et al.
Publicado: (2020)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
por: Criner, Gerard, et al.
Publicado: (2023)

The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade
por: Jones, Christopher A., et al.
Publicado: (2016)

Generalized Propensity Score Matching with Multilevel Treatment Options
por: Baser, Onur
Publicado: (2013)

Applied Comparison of Meta-analysis Techniques
por: Wang, Li, et al.
Publicado: (2013)

Burden of bacterial upper respiratory tract pathogens in school children of Nepal
por: Thapa, Sangita, et al.
Publicado: (2017)

Succincta Descriptio Febris Malagæ nuper sævientis
Publicado: (1805)

5‐HT7 receptors expressed in the mouse parafacial region are not required for respiratory chemosensitivity
por: Shi, Yingtang, et al.
Publicado: (2022)

Prevalence of respiratory symptoms at two time points in a population of children in Manchester—a cohort study
por: Linehan, Mary F, et al.
Publicado: (2012)

Neutrophils drive alveolar macrophage IL-1β release during respiratory viral infection
por: Peiró, Teresa, et al.
Publicado: (2018)

Narrative review of primary care point-of-care testing (POCT) and antibacterial use in respiratory tract infection (RTI)
por: Cooke, Jonathan, et al.
Publicado: (2015)

Multicenter Evaluation of QIAstat-Dx Respiratory Panel V2 for Detection of Viral and Bacterial Respiratory Pathogens
por: Boers, Stefan A., et al.
Publicado: (2020)

Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case–control study protocol
por: Bhuiyan, Mejbah Uddin, et al.
Publicado: (2018)

Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children()()
por: Ruohola, Aino, et al.
Publicado: (2000)

Understanding the risk of transmission of respiratory viral infections in childcare centres: protocol for the DISeases TrANsmission in ChildcarE (DISTANCE) multicentre cohort study
por: Shi, Chao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uoiajjfueo402d1n2nhrfk2hbg